Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT05814640 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Sequenced Treatment Alternatives to Relieve Adolescent Depression (STAR-AD)

Study acronym: STAR-AD
StatusRecruiting
PhasePhase 1/2
Started
View on ClinicalTrials.gov ↗

Record History

  1. Primary completion date: Dec 31, 2025 to Dec 31, 2026v5
  2. Collaborators: 4 to 3v4 See this version in full on ClinicalTrials.gov ↗
  3. Collaborators: 1 to 4 Study description expanded, about 5 words · Study title expanded, about 2 wordsv3 Show 2 more changesShow less
    • Study description expanded, about 5 words
    • Study title expanded, about 2 words

    See this version in full on ClinicalTrials.gov ↗

  4. Secondary endpoints: details revised at 3 of 9 entries Study title shortened, about 8 wordsv2 Show 1 more changeShow less
    • Study title shortened, about 8 words

    See this version in full on ClinicalTrials.gov ↗

  5. Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
This project aims to investigate the effectiveness of existing common antidepressants and to provide new evidence for depressed children and adolescents who are not responding to their first treatment.
Trial Details
NCT Number NCT05814640
Lead Sponsor First Affiliated Hospital of Chongqing Medical University
Collaborators: The Second Affiliated Hospital of Chongqing Medical University, Second Xiangya Hospital of Central South University, Children's Hospital of Chongqing Medical University
Conditions Depression, Sequestra
Enrollment 520 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov